The Journey for Fortis and our initial product, cueStim, began at the University of Galway, within the esteemed Human Movement laboratory at the CURAM Centre for Research in Medical Devices. The cueStim team was supported by approximately €3 Million in funding from the University and various funding bodies including Enterprise Ireland, Science Foundation Ireland, the Irish Research Council and the European Commission. In March 2024, Fortis licensed all the intellectual property developed by the team (10 issued patents) and spun out from the University, bringing the entire development team with us.
Fortis Medical Devices is committed to significantly improving the lives of people with gait impairments stemming from Parkinson’s disease or other neurological disorders such as Multiple Sclerosis and Stroke. Our goal is to create solutions that are easy to use, clinically effective, and capable of addressing significant unmet needs in the market.
Our patent protected cueStim device, for Parkinson’s, is designed to be discreet, efficient, and capable of integrating seamlessly into the everyday routines of patients while increasing the patient’s independence and decreasing the burden on their caregivers and the healthcare system that supports them.
Fortis Medical Devices operates with a global perspective, maintaining substantial operations in both Ireland and the U.S. This dual presence enables us to tap into a diverse pool of resources, expertise, and markets, positioning us effectively for international growth. While continuing to work closely with Irish and European funding bodies, the company is strategically focusing its Series A fundraising efforts primarily in the U.S., the world's largest homogenous market and the initial market entry target for cueStim.
We operate a virtual structure designed to maximize efficiency and scalability. By outsourcing functions such as manufacturing, logistics, and other operations to trusted partners, the company maintains low fixed costs, ensuring high flexibility and the ability to scale quickly as demand grows. This strategic approach enables Fortis to focus resources on innovation and quality while keeping capital expenditure minimal. The flexibility of this model allows us to respond rapidly to market needs and opportunities, positioning the company for sustained growth and success across multiple regions.
